Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

201 ta ish

Ish: Targeted Protein Degradation and Delivery Strategies in the Context of Neurological Disorders

  1. Polymeric Nanoparticles for Drug Delivery

    Maximilian A. Beach, Umeka Nayanathara, Yanting Gao +4

    Sharh maqolaOchiq kirish20247 iqtibos
    ABI

  2. Engineering precision nanoparticles for drug delivery

    Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley +3

    Sharh maqola20207 iqtibos
    ABI

  3. Extracellular vesicles as a next-generation drug delivery platform

    Inge K. Herrmann, Matthew J. A. Wood, Gregor Fuhrmann

    Sharh maqolaOchiq kirish20216 iqtibos
    ABI

  4. Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

    Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4

    MaqolaOchiq kirishProtein Degradation and InhibitorsBiomolecules20264 iqtibos
    ABI

  5. mTOR: a pharmacologic target for autophagy regulation

    Young Chul Kim, Kun‐Liang Guan

    Sharh maqolaOchiq kirish20154 iqtibos
    ABI

  6. Preparation of pegylated nano-liposomal formulation containing SN-38: In vitro characterization and in vivo biodistribution in mice

    Fatemeh Atyabi, Anahita Farkhondehfai, Farnaz Esmaeili +1

    MaqolaOchiq kirish20093 iqtibos
    ABI

  7. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease

    Evandro Fei Fang, Yujun Hou, Konstantinos Palikaras +17

    MaqolaOchiq kirish20193 iqtibos
    ABI

  8. Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer

    Ryan A. Bottens, Tohru Yamada

    Sharh maqolaOchiq kirish20223 iqtibos
    ABI

  9. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives

    Lei Zhong, Yueshan Li, Liang Xiong +8

    Sharh maqolaOchiq kirish20213 iqtibos
    ABI

  10. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera)

    Chang Hoon Ji, Min Ju Lee, Hee Yeon Kim +5

    Boshqa20223 iqtibos
    ABI

  11. Advances of Stimuli-Responsive Amphiphilic Copolymer Micelles in Tumor Therapy

    Yao Wang, Meng Lin, Tianfei Fan +3

    Sharh maqolaOchiq kirish20242 iqtibos
    ABI

  12. Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy

    Yazhen Wang, Lianyi Yang, C. Yan +8

    MaqolaOchiq kirish20242 iqtibos
    ABI

  13. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner

    Huai-Xiang Hao, Yang Xie, Yue Zhang +16

    Maqola20122 iqtibos
    ABI

  14. Advanced drug delivery systems: Nanotechnology of health design A review

    Javad Safari, Zohre Zarnegar

    Sharh maqolaOchiq kirish20132 iqtibos
    ABI

  15. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery

    Bethany Almeida, Okhil K. Nag, Katherine E. Rogers +1

    Sharh maqola20202 iqtibos
    ABI

  16. Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?

    Ian Churcher

    Sharh maqola20172 iqtibos
    ABI

  17. AUTACs: Cargo-Specific Degraders Using Selective Autophagy

    Daiki Takahashi, Jun Moriyama, Tomoe Y. Nakamura +6

    Maqola20192 iqtibos
    ABI

  18. Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance

    Xin Lin, Hua Xiang, Guoshun Luo

    Sharh maqola20202 iqtibos
    ABI

  19. Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1

    Adam D. Cotton, Duy Nguyen, Josef A. Gramespacher +2

    Maqola20212 iqtibos
    ABI

  20. Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation

    Heng Zhang, Yu Han, Yuanfan Yang +7

    Maqola20212 iqtibos
    ABI

  21. PROTAC targeted protein degraders: the past is prologue

    Miklós Békés, David R. Langley, Craig M. Crews

    Sharh maqola20222 iqtibos
    ABI

  22. Proteolysis-targeting chimeras (PROTACs) in cancer therapy

    Xinyi Li, Wenchen Pu, Qingquan Zheng +3

    Maqola20222 iqtibos
    ABI

  23. Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein–Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases

    Fengzhi Li, Ieman Aljahdali, Xiang Ling

    Sharh maqola20222 iqtibos
    ABI

  24. Targeted Protein Degradation via Lysosomes

    Rishi R. Paudel, Dong Lu, Sandipan Chowdhury +2

    Sharh maqola20222 iqtibos
    ABI

  25. Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology

    Jihoon Lee, Ki Woon Sung, Eun-Jin Bae +12

    Maqola20232 iqtibos
    ABI